German endoscopy technology company Invendo Medical has entered the U.S. market with the installation of its C20 colonoscopy systems at the New York University Langone Medical Center and New York-Presbyterian Hospital/Columbia University Medical Center. Both are well-respected gastro intestinal endoscopy centers. The systems include the Invendoscope SC20 single-use colonoscope. The system is cleared for use in the United States by the U.S. Food and Drug Administration.

The Invendoscope SC20 works via a computer assisted (robotic) “gentle drive” technology, instead of being physically pushed or pulled. All endoscopic functions of the device are performed with a hand-held mechanism. According to Invendo, the device reduces pressure on the colon wall.

“We are proud that two such highly regarded clinical institutions have decided to offer their patients an additional option for colonoscopy,” said John J. Cifarelli, executive vice president of global markets for Invendo Medical. “We are enthusiastic about the potential of our colonoscopy system and are confident that many U.S. patients will appreciate the benefits of the Invendo system when they have to decide which screening method would suit them best.”

Invendo’s U.S. headquarters are in New York, N.Y. The company focuses on the development of disposable endoscopy products in the field of gastroenterology.

News from our sister sites